Loading...
A228850 logo

Rayence Co., Ltd.KOSDAQ:A228850 Stock Report

Market Cap ₩95.4b
Share Price
n/a
1Y-7.6%
7D2.2%
1D0.5%
Portfolio Value
View

Rayence Co., Ltd.

KOSDAQ:A228850 Stock Report

Market Cap: ₩95.4b

Rayence (A228850) Stock Overview

Engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. More details

A228850 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance1/6
Financial Health6/6
Dividends2/6

A228850 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW480,107 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
480,107 investors already sharing narratives

Rayence Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Rayence
Historical stock prices
Current Share Price₩6,060.00
52 Week High₩7,420.00
52 Week Low₩4,835.00
Beta0.47
1 Month Change6.32%
3 Month Change-1.94%
1 Year Change-7.62%
3 Year Change-40.82%
5 Year Change-56.09%
Change since IPO-73.71%

Recent News & Updates

Recent updates

Analysis Article Nov 09

Rayence's (KOSDAQ:228850) Dividend Will Be ₩100.00

Rayence Co., Ltd. ( KOSDAQ:228850 ) will pay a dividend of ₩100.00 on the 17th of April. Based on this payment, the...
Analysis Article Mar 24

Some Investors May Be Willing To Look Past Rayence's (KOSDAQ:228850) Soft Earnings

Shareholders appeared unconcerned with Rayence Co., Ltd.'s ( KOSDAQ:228850 ) lackluster earnings report last week. We...
Analysis Article Aug 12

Lacklustre Performance Is Driving Rayence Co., Ltd.'s (KOSDAQ:228850) Low P/E

Rayence Co., Ltd.'s ( KOSDAQ:228850 ) price-to-earnings (or "P/E") ratio of 5.8x might make it look like a buy right...
Analysis Article May 25

Rayence's (KOSDAQ:228850) Profits May Not Reveal Underlying Issues

The recent earnings posted by Rayence Co., Ltd. ( KOSDAQ:228850 ) were solid, but the stock didn't move as much as we...
Analysis Article Mar 31

We Think Rayence (KOSDAQ:228850) Can Stay On Top Of Its Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article Mar 05

Rayence Co., Ltd. (KOSDAQ:228850) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?

Rayence's (KOSDAQ:228850) stock is up by 8.0% over the past three months. However, the company's financials look a bit...
Analysis Article Feb 17

Will Rayence (KOSDAQ:228850) Multiply In Value Going Forward?

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...
Analysis Article Feb 02

Are Rayence's (KOSDAQ:228850) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. Having said that...
Analysis Article Jan 18

Rayence's(KOSDAQ:228850) Share Price Is Down 44% Over The Past Three Years.

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
Analysis Article Jan 06

Should Rayence Co., Ltd. (KOSDAQ:228850) Be Part Of Your Dividend Portfolio?

Today we'll take a closer look at Rayence Co., Ltd. ( KOSDAQ:228850 ) from a dividend investor's perspective. Owning a...
Analysis Article Dec 25

Income Investors Should Know That Rayence Co., Ltd. (KOSDAQ:228850) Goes Ex-Dividend Soon

Rayence Co., Ltd. ( KOSDAQ:228850 ) stock is about to trade ex-dividend in 3 days. This means that investors who...
Analysis Article Dec 14

At ₩11,100, Is It Time To Put Rayence Co., Ltd. (KOSDAQ:228850) On Your Watch List?

Rayence Co., Ltd. ( KOSDAQ:228850 ), might not be a large cap stock, but it received a lot of attention from a...
Analysis Article Dec 01

Rayence (KOSDAQ:228850) Seems To Use Debt Quite Sensibly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Nov 18

A Look At The Intrinsic Value Of Rayence Co., Ltd. (KOSDAQ:228850)

Does the November share price for Rayence Co., Ltd. (KOSDAQ:228850) reflect what it's really worth? Today, we will...

Shareholder Returns

A228850KR Medical EquipmentKR Market
7D2.2%-8.1%-7.0%
1Y-7.6%-31.9%100.8%

Return vs Industry: A228850 exceeded the KR Medical Equipment industry which returned -31.9% over the past year.

Return vs Market: A228850 underperformed the KR Market which returned 100.8% over the past year.

Price Volatility

Is A228850's price volatile compared to industry and market?
A228850 volatility
A228850 Average Weekly Movement6.7%
Medical Equipment Industry Average Movement8.8%
Market Average Movement9.4%
10% most volatile stocks in KR Market16.9%
10% least volatile stocks in KR Market4.9%

Stable Share Price: A228850 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A228850's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011222YoungKwon Seowww.rayence.com

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-Si TFT X-ray detectors for applications, such as dental, veterinary, AXI, die-casting, 2D/3D inline/offline, pipe inspection, etc. It also provides radiography imaging software products, including Xmaru Pro, Xmaru View V1, Xmaru W, Xmaru RF, Xmaru NDT, Vetview Pro, VXV console, Ez Dent Vet, Xmaru PACS, and VXV PACS. In addition, the company offers medical information systems for veterinary hospitals; and engages in veterinary medical device and medicine wholesale and retail business, as well as research and development of process equipment and deposition materials.

Rayence Co., Ltd. Fundamentals Summary

How do Rayence's earnings and revenue compare to its market cap?
A228850 fundamental statistics
Market cap₩95.36b
Earnings (TTM)₩389.37m
Revenue (TTM)₩124.23b
244.9x
P/E Ratio
0.8x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A228850 income statement (TTM)
Revenue₩124.23b
Cost of Revenue₩78.88b
Gross Profit₩45.35b
Other Expenses₩44.96b
Earnings₩389.37m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)24.74
Gross Margin36.50%
Net Profit Margin0.31%
Debt/Equity Ratio0.4%

How did A228850 perform over the long term?

See historical performance and comparison

Dividends

5.0%
Current Dividend Yield
1,210%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/23 02:19
End of Day Share Price 2026/07/23 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Rayence Co., Ltd. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jongsun ParkEugene Investment & Securities Co Ltd.
Hong-Sik JeongLS Securities Co., Ltd.
Woo-sung JungLS Securities Co., Ltd.